semaglutide cv outcomes cardiovascular trial Effects on in People With Overweight or Obesity (SELECT) rationale and design Cardiovascular Outcomes, Medications like Semaglutide and Tirzepatide

King, the principal investigator for the trials, noted that two other similar drugs, from Pfizer and Concert Pharmaceuticals, are also in development to treat the condition and could be approved by the FDA within the next few years

A diet high in potassium can lead to reduced blood pressure levels and positive effects on heart health (6)

Therefore, it is generally contraindicated in individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Certain people are at greater risk for deficiency because of things like diet, lifestyle, and prescription medications

R., Thomas, A